ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Terrence M. Yau
Richard D. Weisel
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yau, T. M.
Right arrow Articles by Li, R.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yau, T. M.
Right arrow Articles by Li, R.-K.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 2005;79:2056-2063
© 2005 The Society of Thoracic Surgeons

Original article: Cardiovascular

Vascular Endothelial Growth Factor Receptor Upregulation in Response to Cell-Based Angiogenic Gene Therapy

Terrence M. Yau, MD, MS*, Guangming Li, MD, Yaoguang Zhang, MD, Richard D. Weisel, MD, Donald A.G. Mickle, MD, Ren-Ke Li, MD PhD

Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, Department of Surgery, University of Toronto, Heart & Stroke Foundation, Richard Lewar Centre of Excellence, Toronto, Ontario, Canada

Accepted for publication October 18, 2004.

* Address reprint requests to Dr Yau, Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, 4N-470, 200 Elizabeth St, Toronto, Ontario M5G 2C4, Canada (E-mail: terry.yau{at}utoronto.ca).

BACKGROUND: We have previously reported that transplantation of vascular endothelial growth factor transfected cells into myocardial scar enhances angiogenesis. We evaluated the effect of transplanted cell type, time, and region of the heart on expression of the vascular endothelial growth factor receptors fms-like tyrosine kinase-1 (flt-1) and fetal liver kinase-1 (flk-1).

METHODS: Lewis rats underwent myocardial cryoinjury 3 weeks before transplantation with heart cells (a mixed culture of cardiomyocytes, smooth muscle cells, endothelial cells, and fibroblasts), vascular endothelial growth factor transfected heart cells, skeletal myoblasts, vascular endothelial growth factor transfected skeletal myoblasts, or medium (controls) (N = 13 each). Flt-1 and flk-1 expression in the scar, border zone, and normal myocardium were evaluated at 3 days and 1, 2, and 4 weeks by quantitative polymerase chain reaction. Transplanted cells, vascular endothelial growth factor, flt-1, and flk-1 were identified by immunohistology.

RESULTS: Flt-1 and flk-1 levels were low in all areas of control hearts. Upregulation of flt-1 and flk-1 after cell transplantation occurred primarily in host cells in the border zone rather than the scar (zone, p < 0.0001). Flt-1 and flk-1 expression was doubled by heart cells and skeletal myoblasts and increased eightfold by vascular endothelial growth factor transfected heart cells and skeletal myoblasts (group, p < 0.0001). Flk-1 expression peaked at 1 week, whereas flt-1 peaked at 2 weeks (time, p < 0.0001).

CONCLUSIONS: Flk-1 and flt-1 upregulation may mediate the angiogenic effect of cell transplantation and are augmented by vascular endothelial growth factor transgene expression, perhaps through a paracrine effect. Optimizing the angiogenic response to cell transplantation may maximize the benefit of cell transplantation strategies.


Related Article

Invited commentary
Frank W. Sellke
Ann. Thorac. Surg. 2005 79: 2063-2064. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Spiegelstein, C. Kim, Y. Zhang, G. Li, R. D. Weisel, R.-K. Li, and T. M. Yau
Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3311 - H3316.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. M. Yau, C. Kim, G. Li, Y. Zhang, S. Fazel, D. Spiegelstein, R. D. Weisel, and R.-K. Li
Enhanced Angiogenesis With Multimodal Cell-Based Gene Therapy
Ann. Thorac. Surg., March 1, 2007; 83(3): 1110 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. Kim, R.-K. Li, G. Li, Y. Zhang, R. D. Weisel, and T. M. Yau
Effects of Cell-Based Angiogenic Gene Therapy at 6 Months: Persistent Angiogenesis and Absence of Oncogenicity
Ann. Thorac. Surg., February 1, 2007; 83(2): 640 - 646.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. M. Yau, C. Kim, G. Li, Y. Zhang, R. D. Weisel, and R.-K. Li
Maximizing Ventricular Function With Multimodal Cell-Based Gene Therapy
Circulation, August 30, 2005; 112(9_suppl): I-123 - I-128.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Fazel, G. H.L. Tang, D. Angoulvant, M. Cimini, R. D. Weisel, R.-K. Li, and T. M. Yau
Current Status of Cellular Therapy for Ischemic Heart Disease
Ann. Thorac. Surg., June 1, 2005; 79(6): S2238 - S2247.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.